The Goldman Sachs Group Issues Pessimistic Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRG) had its target price dropped by stock analysts at The Goldman Sachs Group from $621.00 to $567.00 in a report issued on Wednesday,MarketScreener reports. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. The Goldman Sachs Group’s price target would suggest a potential upside of 27.99% from the stock’s current price.

ISRG has been the subject of a number of other research reports. BTIG Research reissued a “buy” rating and set a $571.00 target price on shares of Intuitive Surgical in a research report on Wednesday. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Friday, September 26th. Royal Bank Of Canada reissued an “outperform” rating and set a $615.00 target price on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Finally, Evercore ISI boosted their target price on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research report on Tuesday, July 8th. Fourteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $594.19.

Intuitive Surgical Stock Up 1.1%

Shares of ISRG stock opened at $443.01 on Wednesday. The company has a market cap of $158.81 billion, a PE ratio of 61.79, a price-to-earnings-growth ratio of 4.59 and a beta of 1.61. Intuitive Surgical has a 12 month low of $425.00 and a 12 month high of $616.00. The business’s 50 day moving average is $464.42 and its two-hundred day moving average is $500.22.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business’s revenue was up 21.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.78 EPS. As a group, equities analysts expect that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In related news, Director Amy L. Ladd sold 336 shares of the company’s stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the sale, the director owned 1,074 shares of the company’s stock, valued at $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is currently owned by company insiders.

Institutional Trading of Intuitive Surgical

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Norway Savings Bank increased its stake in Intuitive Surgical by 53.4% in the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after acquiring an additional 910 shares during the period. IronOak Wealth LLC. bought a new stake in Intuitive Surgical in the second quarter valued at about $1,099,000. Trust Co. of Oklahoma bought a new stake in Intuitive Surgical in the second quarter valued at about $363,000. Neville Rodie & Shaw Inc. increased its stake in Intuitive Surgical by 11.9% in the second quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after acquiring an additional 1,110 shares during the period. Finally, Banque Pictet & Cie SA increased its stake in Intuitive Surgical by 12.1% in the second quarter. Banque Pictet & Cie SA now owns 37,768 shares of the medical equipment provider’s stock valued at $20,524,000 after acquiring an additional 4,085 shares during the period. Institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.